On the restricted mean survival time curve in survival analysis
From MaRDI portal
Publication:2805205
DOI10.1111/biom.12384zbMath1393.62113OpenAlexW1867182292WikidataQ40612925 ScholiaQ40612925MaRDI QIDQ2805205
Hajime Uno, Brian Claggett, L. Tian, Marc A. Pfeffer, Lihui Zhao, Lorenzo Trippa, L. J. Wei, Scott D. Solomon
Publication date: 10 May 2016
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://biostats.bepress.com/cgi/viewcontent.cgi?article=1195&context=harvardbiostat
Gaussian processmartingalesurvival functionsimultaneous confidence bandequivalence/noninferiority study
Applications of statistics to biology and medical sciences; meta analysis (62P10) Reliability and life testing (62N05)
Related Items
Testing equivalence of survival before but not after end of follow-up ⋮ Nonparametric inference in the accelerated failure time model using restricted means ⋮ Intention-to-treat comparisons in randomized trials ⋮ Regression analysis of restricted mean survival time based on pseudo-observations for competing risks data ⋮ On the empirical choice of the time window for restricted mean survival time ⋮ Nonparametric estimation in an illness‐death model with component‐wise censoring ⋮ Nonparametric Inference of General While-Alive Estimands for Recurrent Events ⋮ Restricted survival benefit with right‐censored data ⋮ Restricted mean survival time as a function of restriction time ⋮ On restricted mean time in favor of treatment ⋮ Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions ⋮ Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves ⋮ Modeling restricted mean survival time under general censoring mechanisms ⋮ Subtleties in the interpretation of hazard contrasts ⋮ A nonparametric statistical method for two crossing survival curves ⋮ Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards ⋮ Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study ⋮ On the targets of inference with multivariate failure time data ⋮ Quantifying treatment differences in confirmatory trials under non-proportional hazards
Cites Work
- Large sample behaviour of the product-limit estimator on the whole line
- Regression analysis of restricted mean survival time based on pseudo-observations
- Estimating subject-specific survival functions under the accelerated failure time model
- Double Inverse-Weighted Estimation of Cumulative Treatment Effects Under Nonproportional Hazards and Dependent Censoring
- Causal Inference on the Difference of the Restricted Mean Lifetime Between Two Groups
- Nonparametric Estimation from Incomplete Observations
- Calibrating parametric subject-specific risk estimation
- Checking the Cox model with cumulative sums of martingale-based residuals
- A consistent estimator for the distribution of quality adjusted survival time
- Simultaneous Confidence Intervals for the Difference of Two Survival Functions
- Sequential Methods for Comparing Years of Life Saved in the Two‐Sample Censored Data Problem
- Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time
- On the Cox Model With Time-Varying Regression Coefficients
